Lazari Capital Management, Inc. Merck & Co., Inc. Transaction History
Lazari Capital Management, Inc.
- $184 Billion
- Q1 2024
A detailed history of Lazari Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 2,502 shares of MRK stock, worth $314,676. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,502
Previous 2,388
4.77%
Holding current value
$314,676
Previous $260 Million
26.83%
% of portfolio
0.18%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,770Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.09 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...